2018
DOI: 10.1007/s40272-018-0313-1
| |Summarize |Cite
|
Sign up to set email alerts

An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients

Abstract: Lung transplantation can offer life-prolonging therapy to children with otherwise terminal end-stage lung disease. However, infectious complications, like those experienced by their adult counterparts, are a significant cause of morbidity and mortality. These include bacteria, viruses, and fungi that infect the patient pretransplant and those that may be acquired from the donor or by the recipient in the months to years posttransplant. An understanding of the approach to the management of each potential infect… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
7
1
0
0

Citation Types

0
3
0
0

Year Published

Range
2021
2021
2026
2026

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

Cited by 8 publications

(3 citation statements)

References 166 publications

0
3
0
0
Order By: Relevance
How the paper below cites the one you are viewing
“…This finding is not surprising given their prolonged, life‐long exposure to immunosuppression regimens containing calcineurin inhibitors, which have well‐documented cumulative nephrotoxicity risks [32, 33]. Additionally, the recurrent use of post‐transplant antimicrobials for infectious prophylaxis and targeted therapy increases the risk of acute and chronic kidney injury [34–36]. Despite rigorous clinical surveillance, infection emerged as the second leading cause of death following graft failure in the re‐LTx cohort, highlighting the heightened vulnerability to opportunistic pathogens induced by cumulative immunosuppression and intensive, chronic lymphodepletion protocols.…”
Section: Discussion
mentioning
confidence: 99%